✦ LIBER ✦

Mechanisms of bone fragility in a mouse model of glucocorticoid-treated rheumatoid arthritis: Implications for insufficiency fracture risk

✍ Scribed by Takahata, Masahiko; Maher, Jason R.; Juneja, Subhash C.; Inzana, Jason; Xing, Lianping; Schwarz, Edward M.; Berger, Andrew J.; Awad, Hani A.

Book ID: 118752656
Publisher: John Wiley and Sons
Year: 2012
Tongue: English
Weight: 791 KB
Volume: 64
Category: Article
ISSN: 0004-3591
DOI: 10.1002/art.34639

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Bone fragility beyond strength and miner

Bone fragility beyond strength and mineral density: Raman spectroscopy predicts femoral fracture toughness in a murine model of rheumatoid arthritis

✍ Inzana, Jason A.; Maher, Jason R.; Takahata, Masahiko; Schwarz, Edward M.; Berge 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 1017 KB

Effects of disease-modifying antirheumat

Effects of disease-modifying antirheumatic drugs on nonvertebral fracture risk in rheumatoid arthritis: A population-based cohort study

✍ Seo Young Kim; Sebastian Schneeweiss; Jun Liu; Daniel H Solomon 📂 Article 📅 2012 🏛 American Society for Bone and Mineral Research 🌐 English ⚖ 150 KB

Effects of 1 to 3 years' treatment with

Effects of 1 to 3 years' treatment with alendronate on mechanical properties of the femoral shaft in a canine model: Implications for subtrochanteric femoral fracture risk

✍ David B. Burr; Tamim Diab; Andrew Koivunemi; Mark Koivunemi; Matthew R. Allen 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 78 KB 👁 2 views

## Abstract Bisphosphonate (BP) treatment used to prevent bone loss in postmenopausal osteoporosis has recently been implicated in an apparent increase in subtrochanteric femoral fractures. Previous work showed that BPs can reduce the energy to fracture of cancellous bone, but limited data exist on